spacer
home > ebr > > minimising volume, maximising returns
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

Orphan Drugs and Rare Diseases

20-21 October 2014, Holiday Inn Regents Park Hotel, London, UK

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and theEarly Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments.
More info >>

 
News and Press Releases

Camargo Strengthens Research Team and Therapeutic Expertise

(Cincinnati, Ohio; July 23, 2014) –Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, expands its research team and therapeutic expertise with the addition of Dr. Wen-Yee Choi, Dr. Jillian Orans, Dr. Vien Lai and Kathryn Kemme.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement